Ma Huang

69 interactions 2 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Linezolid Injection
1 Major 68 Moderate
All (69) Major (1) Moderate (68)

Moderate

Ma Huang Irbesartan Avapro Reduced effectiveness of angiotensin II receptor antagonists Details Ma Huang Isradipine DynaCirc® Reduced hypotensive effect of calcium channel blockers Details Ma Huang Ketoprofen Actron® Increased risk of developing gastric mucosal lesions Details Ma Huang Ketorolac Acular Increased risk of developing gastric mucosal lesions Details Ma Huang Ketorolac Injection Acular Increased risk of developing gastric mucosal lesions Details Ma Huang Ketorolac Nasal Spray Sprix Increased risk of developing gastric mucosal lesions Details Ma Huang Ketorolac Ophthalmic Acular Increased risk of developing gastric mucosal lesions Details Ma Huang Labetalol Normodyne® Reduced hypotensive effect of beta-adrenergic blockers Details Ma Huang Levobunolol Ophthalmic AKBeta® Reduced hypotensive effect of beta-adrenergic blockers Details Ma Huang Losartan Arbli Reduced effectiveness of angiotensin II receptor antagonists Details Ma Huang Meclofenamate Meclodium® Increased risk of developing gastric mucosal lesions Details Ma Huang Mefenamic Acid Ponstel® Increased risk of developing gastric mucosal lesions Details Ma Huang Meloxicam Alloxate Increased risk of developing gastric mucosal lesions Details Ma Huang Meloxicam Injection Alloxate Increased risk of developing gastric mucosal lesions Details Ma Huang Methyldopa Aldomet® Reduced hypotensive effect of methyldopa Details Ma Huang Minoxidil Loniten® Reduced hypotensive effect of minoxidil Details Ma Huang Minoxidil Topical Rogaine Reduced hypotensive effect of minoxidil Details Ma Huang Moexipril Univasc® Reduced effectiveness of angiotensin converting enzyme inhibitors Details Ma Huang Nabumetone Relafen Increased risk of developing gastric mucosal lesions Details Ma Huang Nadolol Corgard Reduced hypotensive effect of beta-adrenergic blockers Details Ma Huang Naproxen Aleve Increased risk of developing gastric mucosal lesions Details Ma Huang Nebivolol Bystolic Reduced hypotensive effect of beta-adrenergic blockers Details Ma Huang Nicardipine Cardene Reduced hypotensive effect of calcium channel blockers Details Ma Huang Nifedipine Adalat® Reduced hypotensive effect of calcium channel blockers Details Ma Huang Nimodipine Nimotop Reduced hypotensive effect of calcium channel blockers Details Ma Huang Nisoldipine Sular Reduced hypotensive effect of calcium channel blockers Details Ma Huang Olmesartan Benicar Reduced effectiveness of angiotensin II receptor antagonists Details Ma Huang Penbutolol Levatol® Reduced hypotensive effect of beta-adrenergic blockers Details Ma Huang Perindopril Aceon Reduced effectiveness of angiotensin converting enzyme inhibitors Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.